Výsledky vyhledávání - "CLIA, chemiluminescent immunoassay"

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees

Autor: Binjian, Liu, Xibin, Su, George, Yu, Shuling, Yang, Feng, Wang, Tao, Huang, Liuyong, Zhou, Zhiqiang, Hui, Yixian, Liao, Yuan, Qiu, Juan, Huang, Hong, Gao, Justin, Liu, Yaoqi, Zhong

Publikováno v: International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 115, Iss, Pp 116-125 (2022)

Objectives A specific and sensitive automated chemiluminescent immunoassay (CLIA) was developed to detect neutralizing antibody (NAb) levels. This assay can be used for the diagnosis of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) inf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a12fca285c8708d26e6d035e29c54e
http://europepmc.org/articles/PMC8660141

Zobrazit plný text záznamu

Typical CT findings of COVID-19 pneumonia in patients presenting with repetitive negative RT-PCR

Autor: Giovanni Fontanella, Elio Bignardi, Carlo Brogna, Barbara Brogna, Lanfranco Musto, Emerico Maria Mazza, Antonia Megliola, Martino Alberigo, M Grappone, Petronilla Salvatore

Publikováno v: Radiography (London, England : 1995)

Multiple polymerase chain reaction (RT-PCR) is considered the gold standard diagnostic investigation for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). However, false negative multiple po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5b2a721a86c330f0bffe1a020ab0fb
https://doi.org/10.1016/j.radi.2020.09.012

Zobrazit plný text záznamu

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay

Autor: Michael Neumaier, Verena Haselmann, Peter Findeisen, Margot Thiaucourt, Catharina Gerhards, Maximilian Kittel, Maria-Christina Muth

Publikováno v: International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 632-638 (2021)

Background The detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is mandatory for the diagnosis, retrospective assessment of disease progression, and correct evaluation of the current infection situation in the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f998234eed80203147468f2d67d16359
https://doi.org/10.1016/j.ijid.2021.02.024

Zobrazit plný text záznamu

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients

Autor: Lorenzo Azzi, Daniela Dalla Gasperina, Giovanni Veronesi, Mariam Shallak, Giuseppe Ietto, Domenico Iovino, Andreina Baj, Francesco Gianfagna, Vittorio Maurino, Daniele Focosi, Fabrizio Maggi, Marco Mario Ferrario, Francesco Dentali, Giulio Carcano, Angelo Tagliabue, Lorenzo Stefano Maffioli, Roberto Sergio Accolla, Greta Forlani

Publikováno v: EBioMedicine, Vol 75, Iss, Pp 103788-(2022)
EBioMedicine

Summary: Background: Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing antibodies in serum protecting against COVID-19, it has not been studied in detail whether it could generate specific immunity at mucosal sites, which rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb4adce58d3fba0b1536acd3fc892eb
http://hdl.handle.net/11383/2130084

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody

Autor: Bruno Lina, Mary Anne Trabaud, Vinca Icard, Vanessa Escuret, Marie Paule Milon, Antonin Bal

Publikováno v: Journal of Clinical Virology
Journal of Clinical Virology, Elsevier, 2020, 132, pp.104613-. ⟨10.1016/j.jcv.2020.104613⟩
Journal of Clinical Virology, 2020, 132, pp.104613-. ⟨10.1016/j.jcv.2020.104613⟩

Highlights • 8 commercial assays detecting similar class of SARS-CoV-2 -specific antibodies. • Discrepancies found not linked to sensitivity, target Ag, total vs IgG antibodies. • False negative results possible in pauci-symptomatic subjects.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7b88007f9cbe94c80099356ccbf219
https://hal.archives-ouvertes.fr/hal-03491361

Zobrazit plný text záznamu

Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays

Autor: Sigi Van den Wijngaert, Olivier Vandenberg, Frédéric Cotton, Hafid Dahma, Isabel Montesinos, Cecile Duterme, Fleur Wolff

Publikováno v: Diagnostic Microbiology and Infectious Disease
Diagnostic microbiology and infectious disease, 98 (3

Introduction: SARS-CoV-2 seroconversion is important for epidemiological studies as well as contact tracing. Material and methods: The antibody response against SARS-CoV-2 was examined in 111 patients with a positive qRT-PCR. Seroconversion was asses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d549ee57b90fd3353e5599d083cb911
https://pubmed.ncbi.nlm.nih.gov/32829098

Zobrazit plný text záznamu

Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals

Autor: Laurence Galanti, B. de fays, M Closset, B. Delaere, E. Catry, Hugues Jacqmin, Olivier Denis, T. Laurent, Benjamin Lardinois, T.-D. Huang, François Mullier, Magali Dodémont, I. Saad Albichr

Publikováno v: Journal of virological methods, Vol. 289, p. 114060 (2020)
Journal of Virological Methods

Highlights • Hospitalized patients seroconverted at ≥ 3 weeks pso. • Ambulatory symptomatic individuals seroconverted at 14 days pso. • Illness’ severity degree and infection phase impacted the longitudinal Ab changes. • Five “severe-to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99124cd40237387b3299d81609e17fb
https://hdl.handle.net/2078.1/241905

Zobrazit plný text záznamu

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients

Autor: Leonie Mayer, Anahita Fathi, Thomas Theo Brehm, Martina Sterneck, Jacqueline Jahnke-Triankowski, Golda M. Schaub, Darius Ferenc Ruether, Marylyn M. Addo, Julian Schulze zur Wiesch, Marc Lütgehetmann, Ansgar W. Lohse, Lutz Fischer, Paul M. Duengelhoef, Armin Hoffmann, Friedrich Haag, Malte H. Wehmeyer

Publikováno v: Clinical Gastroenterology and Hepatology

Detailed information on the immune response after second vaccination of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is largely missing. We aimed at comparing the va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64a4ab48727197be8febb1a48ae204dc
https://doi.org/10.1016/j.cgh.2021.09.003

Zobrazit plný text záznamu

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

Autor: Vilte E. Barakauskas, Inna Sekirov, Mel Krajden, Annie Mak, Rohit Vijh, Janet Simons, Darrel Cook, Althea S. Hayden, Meghan McLennan, Muhammad Morshed, Shazia Masud, Brandon Bates, David M. Goldfarb, Laura Burns, Navdeep Chahil, Marthe Charles, Paul N. Levett

Publikováno v: Journal of Clinical Virology

Background SARS-CoV-2 antibody testing is required for estimating population seroprevalence and vaccine response studies. It may also increase case identification when used as an adjunct to routine molecular testing. We performed a validation study a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3023217864aa0279895139039f64fc
https://doi.org/10.1016/j.jcv.2021.104914

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání